VIDEO: Dupilumab and adjuvant tacrolimus improves severity of AD, new study shows

According to a new study, patients with atopic dermatitis (AD) are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus as opposed to dupilumab alone.